M&A Deal Summary |
|
|---|---|
| Date | 2017-09-05 |
| Target | Metabolomic Discoveries |
| Sector | Life Science |
| Buyer(s) | Metabolon |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
Metabolon is a health technology company focused on the use of metabolomics in precision medicine. Metabolon’s expertise is also accelerating research and product development across the pharmaceutical, biotechnology, consumer products, agriculture and nutrition industries, as well as academic and government organizations. Metabolon was founded in 2000 and is based in Morrisville, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-01 |
Lipomics Technologies
West Sacramento, California, United States Lipomics provides metabolite profiling, biomarker discovery and metabolism consultation services to industry and academia. Its quantitative profiling assays are used to develop an understanding of metabolism in disease, the effects of drugs or foods on metabolism and for identifying biomarkers for use in clinical trials and as commercial products. Lipomics’ expertise in lipid and intermediary metabolism drives its development of research and clinical assays. Its TrueMass® Profiling is a suite of analytical panels that provide comprehensive and quantitative coverage of key pathways involved in metabolic, cardiovascular and inflammatory conditions. |
Buy | - |
